Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-1992 | 12-1991 | 09-1991 | 06-1991 | 03-1991 | |
| Sales | 3,518 | 3,268 | 1,872 | 1,742 | 431 |
| Cost of Goods | 0 | -5,300 | 2,435 | 2,865 | 0 |
| Gross Profit | 2,157 | 8,568 | -563 | -1,124 | 431 |
| Operating Expenses | 6,657 | 12,458 | 2,479 | 1,609 | 1,343 |
| Operating Income | -3,139 | -4,189 | -2,607 | -1,867 | -912 |
| Interest Expense | 139 | 58 | 24 | 6 | 1 |
| Other Income | 0 | 1,910 | 1,753 | 1,532 | 0 |
| Pre-tax Income | -3,277 | -2,337 | -877 | -341 | -913 |
| Net Income Continuous | -3,277 | -2,337 | -877 | -341 | -913 |
| Net Income Discontinuous | -1,998,000 | 0 | 0 | 0 | 0 |
| Net Income | $-3,277 | $-2,337 | $-877 | $-341 | $-913 |
| EPS Basic Total Ops | -0.21 | -0.15 | -0.06 | -0.02 | -0.17 |
| EPS Basic Continuous Ops | -0.21 | -0.15 | -0.06 | -0.02 | -0.17 |
| EPS Basic Discontinuous Ops | -130.06 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -0.21 | -0.15 | -0.06 | -0.02 | -0.17 |
| EPS Diluted Continuous Ops | -0.21 | -0.15 | -0.06 | -0.02 | -0.17 |
| EPS Diluted Discontinuous Ops | -130.16 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-3,139 | $-4,189 | $-2,607 | $-1,867 | $-912 |